In addition to AFP, other serum biomarkers, such as the neutrophils-to-lymphocytes ratio (NLR), AFP-L3 and des-γ-carboxyprothrombin (DCP), resulted to be surrogate markers of tumor biology and have been considered for inclusion in pre-transplant prognostic models [41,42,43,44]. The gene discussed is AFP; the disease is neoplasm.